nodes	percent_of_prediction	percent_of_DWPC	metapath
Medroxyprogesterone Acetate—Methylprednisolone—psoriatic arthritis	0.283	1	CrCtD
Medroxyprogesterone Acetate—breast cancer—Dexamethasone—psoriatic arthritis	0.12	0.5	CpDpCtD
Medroxyprogesterone Acetate—breast cancer—Betamethasone—psoriatic arthritis	0.12	0.5	CpDpCtD
Medroxyprogesterone Acetate—PGR—Betamethasone—psoriatic arthritis	0.0342	0.186	CbGbCtD
Medroxyprogesterone Acetate—NR3C1—Methylprednisolone—psoriatic arthritis	0.0268	0.146	CbGbCtD
Medroxyprogesterone Acetate—NR3C1—Triamcinolone—psoriatic arthritis	0.0203	0.111	CbGbCtD
Medroxyprogesterone Acetate—PGR—Dexamethasone—psoriatic arthritis	0.0199	0.108	CbGbCtD
Medroxyprogesterone Acetate—NR3C1—Betamethasone—psoriatic arthritis	0.0175	0.0952	CbGbCtD
Medroxyprogesterone Acetate—NR3C1—Prednisolone—psoriatic arthritis	0.0172	0.0939	CbGbCtD
Medroxyprogesterone Acetate—NR3C1—Prednisone—psoriatic arthritis	0.0163	0.0887	CbGbCtD
Medroxyprogesterone Acetate—NR3C1—Dexamethasone—psoriatic arthritis	0.0102	0.0554	CbGbCtD
Medroxyprogesterone Acetate—Potassium Canrenoate—Prednisone—psoriatic arthritis	0.00722	0.0292	CrCrCtD
Medroxyprogesterone Acetate—Potassium Canrenoate—Prednisolone—psoriatic arthritis	0.00704	0.0285	CrCrCtD
Medroxyprogesterone Acetate—Medrysone—Methylprednisolone—psoriatic arthritis	0.00668	0.027	CrCrCtD
Medroxyprogesterone Acetate—Flurandrenolide—Methylprednisolone—psoriatic arthritis	0.00621	0.0251	CrCrCtD
Medroxyprogesterone Acetate—Flurandrenolide—Dexamethasone—psoriatic arthritis	0.00611	0.0247	CrCrCtD
Medroxyprogesterone Acetate—Flurandrenolide—Betamethasone—psoriatic arthritis	0.00611	0.0247	CrCrCtD
Medroxyprogesterone Acetate—Medrysone—Prednisolone—psoriatic arthritis	0.00595	0.0241	CrCrCtD
Medroxyprogesterone Acetate—Hydrocortamate—Methylprednisolone—psoriatic arthritis	0.00581	0.0235	CrCrCtD
Medroxyprogesterone Acetate—Cortisone acetate—Methylprednisolone—psoriatic arthritis	0.00563	0.0228	CrCrCtD
Medroxyprogesterone Acetate—Flurandrenolide—Prednisolone—psoriatic arthritis	0.00553	0.0224	CrCrCtD
Medroxyprogesterone Acetate—Prednicarbate—Methylprednisolone—psoriatic arthritis	0.00546	0.0221	CrCrCtD
Medroxyprogesterone Acetate—Prednicarbate—Dexamethasone—psoriatic arthritis	0.00537	0.0217	CrCrCtD
Medroxyprogesterone Acetate—Prednicarbate—Betamethasone—psoriatic arthritis	0.00537	0.0217	CrCrCtD
Medroxyprogesterone Acetate—Hydrocortamate—Prednisone—psoriatic arthritis	0.0053	0.0214	CrCrCtD
Medroxyprogesterone Acetate—Prednicarbate—Triamcinolone—psoriatic arthritis	0.00525	0.0212	CrCrCtD
Medroxyprogesterone Acetate—Hydrocortamate—Prednisolone—psoriatic arthritis	0.00517	0.0209	CrCrCtD
Medroxyprogesterone Acetate—Cortisone acetate—Prednisone—psoriatic arthritis	0.00514	0.0208	CrCrCtD
Medroxyprogesterone Acetate—Cortisone acetate—Prednisolone—psoriatic arthritis	0.00501	0.0203	CrCrCtD
Medroxyprogesterone Acetate—Prednicarbate—Prednisone—psoriatic arthritis	0.00498	0.0202	CrCrCtD
Medroxyprogesterone Acetate—Fluoxymesterone—Betamethasone—psoriatic arthritis	0.00494	0.02	CrCrCtD
Medroxyprogesterone Acetate—Fluoxymesterone—Dexamethasone—psoriatic arthritis	0.00494	0.02	CrCrCtD
Medroxyprogesterone Acetate—Fludrocortisone—Methylprednisolone—psoriatic arthritis	0.00489	0.0198	CrCrCtD
Medroxyprogesterone Acetate—Prednicarbate—Prednisolone—psoriatic arthritis	0.00486	0.0197	CrCrCtD
Medroxyprogesterone Acetate—Fluoxymesterone—Triamcinolone—psoriatic arthritis	0.00483	0.0195	CrCrCtD
Medroxyprogesterone Acetate—Fludrocortisone—Betamethasone—psoriatic arthritis	0.00481	0.0195	CrCrCtD
Medroxyprogesterone Acetate—Fludrocortisone—Dexamethasone—psoriatic arthritis	0.00481	0.0195	CrCrCtD
Medroxyprogesterone Acetate—Fludrocortisone—Triamcinolone—psoriatic arthritis	0.0047	0.019	CrCrCtD
Medroxyprogesterone Acetate—Fluorometholone—Methylprednisolone—psoriatic arthritis	0.00454	0.0184	CrCrCtD
Medroxyprogesterone Acetate—Fluoxymesterone—Prednisolone—psoriatic arthritis	0.00447	0.0181	CrCrCtD
Medroxyprogesterone Acetate—Fluorometholone—Betamethasone—psoriatic arthritis	0.00447	0.0181	CrCrCtD
Medroxyprogesterone Acetate—Fluorometholone—Dexamethasone—psoriatic arthritis	0.00447	0.0181	CrCrCtD
Medroxyprogesterone Acetate—Fludrocortisone—Prednisone—psoriatic arthritis	0.00446	0.0181	CrCrCtD
Medroxyprogesterone Acetate—Fluorometholone—Triamcinolone—psoriatic arthritis	0.00437	0.0177	CrCrCtD
Medroxyprogesterone Acetate—Fludrocortisone—Prednisolone—psoriatic arthritis	0.00436	0.0176	CrCrCtD
Medroxyprogesterone Acetate—Progesterone—Prednisolone—psoriatic arthritis	0.00436	0.0176	CrCrCtD
Medroxyprogesterone Acetate—Methyltestosterone—Prednisone—psoriatic arthritis	0.00435	0.0176	CrCrCtD
Medroxyprogesterone Acetate—Methyltestosterone—Prednisolone—psoriatic arthritis	0.00425	0.0172	CrCrCtD
Medroxyprogesterone Acetate—Methylprednisolone—Dexamethasone—psoriatic arthritis	0.00418	0.0169	CrCrCtD
Medroxyprogesterone Acetate—Methylprednisolone—Betamethasone—psoriatic arthritis	0.00418	0.0169	CrCrCtD
Medroxyprogesterone Acetate—Fluorometholone—Prednisone—psoriatic arthritis	0.00414	0.0168	CrCrCtD
Medroxyprogesterone Acetate—Methylprednisolone—Triamcinolone—psoriatic arthritis	0.00408	0.0165	CrCrCtD
Medroxyprogesterone Acetate—Fluorometholone—Prednisolone—psoriatic arthritis	0.00404	0.0164	CrCrCtD
Medroxyprogesterone Acetate—Hydrocortisone—Methylprednisolone—psoriatic arthritis	0.00399	0.0161	CrCrCtD
Medroxyprogesterone Acetate—Hydrocortisone—Betamethasone—psoriatic arthritis	0.00392	0.0159	CrCrCtD
Medroxyprogesterone Acetate—Hydrocortisone—Dexamethasone—psoriatic arthritis	0.00392	0.0159	CrCrCtD
Medroxyprogesterone Acetate—Methylprednisolone—Prednisone—psoriatic arthritis	0.00387	0.0157	CrCrCtD
Medroxyprogesterone Acetate—Hydrocortisone—Triamcinolone—psoriatic arthritis	0.00383	0.0155	CrCrCtD
Medroxyprogesterone Acetate—Testosterone—Prednisolone—psoriatic arthritis	0.00378	0.0153	CrCrCtD
Medroxyprogesterone Acetate—Methylprednisolone—Prednisolone—psoriatic arthritis	0.00378	0.0153	CrCrCtD
Medroxyprogesterone Acetate—CYP3A4—Methylprednisolone—psoriatic arthritis	0.00374	0.0204	CbGbCtD
Medroxyprogesterone Acetate—Hydrocortisone—Prednisone—psoriatic arthritis	0.00364	0.0147	CrCrCtD
Medroxyprogesterone Acetate—Hydrocortisone—Prednisolone—psoriatic arthritis	0.00355	0.0144	CrCrCtD
Medroxyprogesterone Acetate—CYP2C8—Dexamethasone—psoriatic arthritis	0.00349	0.019	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Triamcinolone—psoriatic arthritis	0.00284	0.0155	CbGbCtD
Medroxyprogesterone Acetate—CYP2C9—Dexamethasone—psoriatic arthritis	0.00244	0.0133	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Betamethasone—psoriatic arthritis	0.00243	0.0133	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Prednisolone—psoriatic arthritis	0.0024	0.0131	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Prednisone—psoriatic arthritis	0.00227	0.0124	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Dexamethasone—psoriatic arthritis	0.00142	0.00773	CbGbCtD
Medroxyprogesterone Acetate—Vertigo—Betamethasone—psoriatic arthritis	2.95e-05	0.000648	CcSEcCtD
Medroxyprogesterone Acetate—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	2.94e-05	0.000648	CcSEcCtD
Medroxyprogesterone Acetate—Syncope—Dexamethasone—psoriatic arthritis	2.94e-05	0.000647	CcSEcCtD
Medroxyprogesterone Acetate—Syncope—Betamethasone—psoriatic arthritis	2.94e-05	0.000647	CcSEcCtD
Medroxyprogesterone Acetate—Infection—Triamcinolone—psoriatic arthritis	2.93e-05	0.000645	CcSEcCtD
Medroxyprogesterone Acetate—Sweating—Methotrexate—psoriatic arthritis	2.93e-05	0.000644	CcSEcCtD
Medroxyprogesterone Acetate—Infection—Methylprednisolone—psoriatic arthritis	2.92e-05	0.000644	CcSEcCtD
Medroxyprogesterone Acetate—Shock—Triamcinolone—psoriatic arthritis	2.9e-05	0.000639	CcSEcCtD
Medroxyprogesterone Acetate—Insomnia—Prednisolone—psoriatic arthritis	2.9e-05	0.000639	CcSEcCtD
Medroxyprogesterone Acetate—Alopecia—Prednisone—psoriatic arthritis	2.9e-05	0.000638	CcSEcCtD
Medroxyprogesterone Acetate—Shock—Methylprednisolone—psoriatic arthritis	2.9e-05	0.000637	CcSEcCtD
Medroxyprogesterone Acetate—Hepatobiliary disease—Methotrexate—psoriatic arthritis	2.89e-05	0.000636	CcSEcCtD
Medroxyprogesterone Acetate—Nervous system disorder—Methylprednisolone—psoriatic arthritis	2.89e-05	0.000635	CcSEcCtD
Medroxyprogesterone Acetate—Loss of consciousness—Betamethasone—psoriatic arthritis	2.88e-05	0.000634	CcSEcCtD
Medroxyprogesterone Acetate—Loss of consciousness—Dexamethasone—psoriatic arthritis	2.88e-05	0.000634	CcSEcCtD
Medroxyprogesterone Acetate—Epistaxis—Methotrexate—psoriatic arthritis	2.88e-05	0.000634	CcSEcCtD
Medroxyprogesterone Acetate—Paraesthesia—Prednisolone—psoriatic arthritis	2.88e-05	0.000634	CcSEcCtD
Medroxyprogesterone Acetate—Tachycardia—Triamcinolone—psoriatic arthritis	2.88e-05	0.000634	CcSEcCtD
Medroxyprogesterone Acetate—Mental disorder—Prednisone—psoriatic arthritis	2.87e-05	0.000633	CcSEcCtD
Medroxyprogesterone Acetate—Tachycardia—Methylprednisolone—psoriatic arthritis	2.87e-05	0.000632	CcSEcCtD
Medroxyprogesterone Acetate—Skin disorder—Methylprednisolone—psoriatic arthritis	2.86e-05	0.000629	CcSEcCtD
Medroxyprogesterone Acetate—Erythema—Prednisone—psoriatic arthritis	2.86e-05	0.000629	CcSEcCtD
Medroxyprogesterone Acetate—Malnutrition—Prednisone—psoriatic arthritis	2.86e-05	0.000629	CcSEcCtD
Medroxyprogesterone Acetate—Hyperhidrosis—Triamcinolone—psoriatic arthritis	2.85e-05	0.000628	CcSEcCtD
Medroxyprogesterone Acetate—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	2.84e-05	0.000626	CcSEcCtD
Medroxyprogesterone Acetate—Convulsion—Dexamethasone—psoriatic arthritis	2.84e-05	0.000625	CcSEcCtD
Medroxyprogesterone Acetate—Convulsion—Betamethasone—psoriatic arthritis	2.84e-05	0.000625	CcSEcCtD
Medroxyprogesterone Acetate—Myalgia—Dexamethasone—psoriatic arthritis	2.79e-05	0.000615	CcSEcCtD
Medroxyprogesterone Acetate—Myalgia—Betamethasone—psoriatic arthritis	2.79e-05	0.000615	CcSEcCtD
Medroxyprogesterone Acetate—Anxiety—Dexamethasone—psoriatic arthritis	2.78e-05	0.000612	CcSEcCtD
Medroxyprogesterone Acetate—Anxiety—Betamethasone—psoriatic arthritis	2.78e-05	0.000612	CcSEcCtD
Medroxyprogesterone Acetate—Discomfort—Dexamethasone—psoriatic arthritis	2.76e-05	0.000607	CcSEcCtD
Medroxyprogesterone Acetate—Discomfort—Betamethasone—psoriatic arthritis	2.76e-05	0.000607	CcSEcCtD
Medroxyprogesterone Acetate—Haemoglobin—Methotrexate—psoriatic arthritis	2.76e-05	0.000607	CcSEcCtD
Medroxyprogesterone Acetate—Hypotension—Methylprednisolone—psoriatic arthritis	2.75e-05	0.000605	CcSEcCtD
Medroxyprogesterone Acetate—Haemorrhage—Methotrexate—psoriatic arthritis	2.74e-05	0.000603	CcSEcCtD
Medroxyprogesterone Acetate—Hepatitis—Methotrexate—psoriatic arthritis	2.74e-05	0.000603	CcSEcCtD
Medroxyprogesterone Acetate—Pharyngitis—Methotrexate—psoriatic arthritis	2.72e-05	0.000599	CcSEcCtD
Medroxyprogesterone Acetate—Urinary tract disorder—Methotrexate—psoriatic arthritis	2.71e-05	0.000596	CcSEcCtD
Medroxyprogesterone Acetate—Urethral disorder—Methotrexate—psoriatic arthritis	2.69e-05	0.000592	CcSEcCtD
Medroxyprogesterone Acetate—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	2.69e-05	0.000592	CcSEcCtD
Medroxyprogesterone Acetate—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	2.68e-05	0.00059	CcSEcCtD
Medroxyprogesterone Acetate—Oedema—Betamethasone—psoriatic arthritis	2.68e-05	0.000589	CcSEcCtD
Medroxyprogesterone Acetate—Oedema—Dexamethasone—psoriatic arthritis	2.68e-05	0.000589	CcSEcCtD
Medroxyprogesterone Acetate—Anaphylactic shock—Dexamethasone—psoriatic arthritis	2.68e-05	0.000589	CcSEcCtD
Medroxyprogesterone Acetate—Anaphylactic shock—Betamethasone—psoriatic arthritis	2.68e-05	0.000589	CcSEcCtD
Medroxyprogesterone Acetate—Insomnia—Triamcinolone—psoriatic arthritis	2.67e-05	0.000587	CcSEcCtD
Medroxyprogesterone Acetate—Insomnia—Methylprednisolone—psoriatic arthritis	2.66e-05	0.000586	CcSEcCtD
Medroxyprogesterone Acetate—Infection—Dexamethasone—psoriatic arthritis	2.66e-05	0.000585	CcSEcCtD
Medroxyprogesterone Acetate—Infection—Betamethasone—psoriatic arthritis	2.66e-05	0.000585	CcSEcCtD
Medroxyprogesterone Acetate—Ill-defined disorder—Prednisone—psoriatic arthritis	2.65e-05	0.000583	CcSEcCtD
Medroxyprogesterone Acetate—Paraesthesia—Triamcinolone—psoriatic arthritis	2.65e-05	0.000583	CcSEcCtD
Medroxyprogesterone Acetate—Feeling abnormal—Prednisolone—psoriatic arthritis	2.64e-05	0.000582	CcSEcCtD
Medroxyprogesterone Acetate—Paraesthesia—Methylprednisolone—psoriatic arthritis	2.64e-05	0.000582	CcSEcCtD
Medroxyprogesterone Acetate—Visual impairment—Methotrexate—psoriatic arthritis	2.64e-05	0.000582	CcSEcCtD
Medroxyprogesterone Acetate—Anaemia—Prednisone—psoriatic arthritis	2.64e-05	0.000581	CcSEcCtD
Medroxyprogesterone Acetate—Shock—Dexamethasone—psoriatic arthritis	2.63e-05	0.00058	CcSEcCtD
Medroxyprogesterone Acetate—Shock—Betamethasone—psoriatic arthritis	2.63e-05	0.00058	CcSEcCtD
Medroxyprogesterone Acetate—Dyspnoea—Triamcinolone—psoriatic arthritis	2.63e-05	0.000579	CcSEcCtD
Medroxyprogesterone Acetate—Nervous system disorder—Betamethasone—psoriatic arthritis	2.62e-05	0.000578	CcSEcCtD
Medroxyprogesterone Acetate—Nervous system disorder—Dexamethasone—psoriatic arthritis	2.62e-05	0.000578	CcSEcCtD
Medroxyprogesterone Acetate—Agitation—Prednisone—psoriatic arthritis	2.62e-05	0.000578	CcSEcCtD
Medroxyprogesterone Acetate—Thrombocytopenia—Dexamethasone—psoriatic arthritis	2.62e-05	0.000577	CcSEcCtD
Medroxyprogesterone Acetate—Thrombocytopenia—Betamethasone—psoriatic arthritis	2.62e-05	0.000577	CcSEcCtD
Medroxyprogesterone Acetate—Tachycardia—Dexamethasone—psoriatic arthritis	2.61e-05	0.000575	CcSEcCtD
Medroxyprogesterone Acetate—Tachycardia—Betamethasone—psoriatic arthritis	2.61e-05	0.000575	CcSEcCtD
Medroxyprogesterone Acetate—Angioedema—Prednisone—psoriatic arthritis	2.61e-05	0.000574	CcSEcCtD
Medroxyprogesterone Acetate—Dyspepsia—Triamcinolone—psoriatic arthritis	2.6e-05	0.000571	CcSEcCtD
Medroxyprogesterone Acetate—Erythema multiforme—Methotrexate—psoriatic arthritis	2.59e-05	0.000571	CcSEcCtD
Medroxyprogesterone Acetate—Dyspepsia—Methylprednisolone—psoriatic arthritis	2.59e-05	0.00057	CcSEcCtD
Medroxyprogesterone Acetate—Hyperhidrosis—Dexamethasone—psoriatic arthritis	2.59e-05	0.000569	CcSEcCtD
Medroxyprogesterone Acetate—Hyperhidrosis—Betamethasone—psoriatic arthritis	2.59e-05	0.000569	CcSEcCtD
Medroxyprogesterone Acetate—Malaise—Prednisone—psoriatic arthritis	2.58e-05	0.000567	CcSEcCtD
Medroxyprogesterone Acetate—Vertigo—Prednisone—psoriatic arthritis	2.57e-05	0.000565	CcSEcCtD
Medroxyprogesterone Acetate—Eye disorder—Methotrexate—psoriatic arthritis	2.56e-05	0.000564	CcSEcCtD
Medroxyprogesterone Acetate—Syncope—Prednisone—psoriatic arthritis	2.56e-05	0.000564	CcSEcCtD
Medroxyprogesterone Acetate—Tinnitus—Methotrexate—psoriatic arthritis	2.56e-05	0.000563	CcSEcCtD
Medroxyprogesterone Acetate—Anorexia—Dexamethasone—psoriatic arthritis	2.55e-05	0.000562	CcSEcCtD
Medroxyprogesterone Acetate—Anorexia—Betamethasone—psoriatic arthritis	2.55e-05	0.000562	CcSEcCtD
Medroxyprogesterone Acetate—Urticaria—Prednisolone—psoriatic arthritis	2.55e-05	0.000561	CcSEcCtD
Medroxyprogesterone Acetate—Cardiac disorder—Methotrexate—psoriatic arthritis	2.54e-05	0.00056	CcSEcCtD
Medroxyprogesterone Acetate—Fatigue—Triamcinolone—psoriatic arthritis	2.54e-05	0.00056	CcSEcCtD
Medroxyprogesterone Acetate—Fatigue—Methylprednisolone—psoriatic arthritis	2.54e-05	0.000558	CcSEcCtD
Medroxyprogesterone Acetate—Loss of consciousness—Prednisone—psoriatic arthritis	2.51e-05	0.000552	CcSEcCtD
Medroxyprogesterone Acetate—Hypotension—Betamethasone—psoriatic arthritis	2.5e-05	0.00055	CcSEcCtD
Medroxyprogesterone Acetate—Hypotension—Dexamethasone—psoriatic arthritis	2.5e-05	0.00055	CcSEcCtD
Medroxyprogesterone Acetate—Angiopathy—Methotrexate—psoriatic arthritis	2.49e-05	0.000548	CcSEcCtD
Medroxyprogesterone Acetate—Immune system disorder—Methotrexate—psoriatic arthritis	2.48e-05	0.000545	CcSEcCtD
Medroxyprogesterone Acetate—Convulsion—Prednisone—psoriatic arthritis	2.47e-05	0.000545	CcSEcCtD
Medroxyprogesterone Acetate—Mediastinal disorder—Methotrexate—psoriatic arthritis	2.47e-05	0.000544	CcSEcCtD
Medroxyprogesterone Acetate—Chills—Methotrexate—psoriatic arthritis	2.46e-05	0.000541	CcSEcCtD
Medroxyprogesterone Acetate—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	2.44e-05	0.000537	CcSEcCtD
Medroxyprogesterone Acetate—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	2.44e-05	0.000537	CcSEcCtD
Medroxyprogesterone Acetate—Myalgia—Prednisone—psoriatic arthritis	2.43e-05	0.000535	CcSEcCtD
Medroxyprogesterone Acetate—Arthralgia—Prednisone—psoriatic arthritis	2.43e-05	0.000535	CcSEcCtD
Medroxyprogesterone Acetate—Feeling abnormal—Triamcinolone—psoriatic arthritis	2.43e-05	0.000535	CcSEcCtD
Medroxyprogesterone Acetate—Feeling abnormal—Methylprednisolone—psoriatic arthritis	2.43e-05	0.000534	CcSEcCtD
Medroxyprogesterone Acetate—Anxiety—Prednisone—psoriatic arthritis	2.42e-05	0.000533	CcSEcCtD
Medroxyprogesterone Acetate—Alopecia—Methotrexate—psoriatic arthritis	2.42e-05	0.000533	CcSEcCtD
Medroxyprogesterone Acetate—Insomnia—Betamethasone—psoriatic arthritis	2.42e-05	0.000533	CcSEcCtD
Medroxyprogesterone Acetate—Insomnia—Dexamethasone—psoriatic arthritis	2.42e-05	0.000533	CcSEcCtD
Medroxyprogesterone Acetate—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	2.41e-05	0.000531	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	2.41e-05	0.00053	CcSEcCtD
Medroxyprogesterone Acetate—Paraesthesia—Dexamethasone—psoriatic arthritis	2.4e-05	0.000529	CcSEcCtD
Medroxyprogesterone Acetate—Paraesthesia—Betamethasone—psoriatic arthritis	2.4e-05	0.000529	CcSEcCtD
Medroxyprogesterone Acetate—Discomfort—Prednisone—psoriatic arthritis	2.4e-05	0.000529	CcSEcCtD
Medroxyprogesterone Acetate—Mental disorder—Methotrexate—psoriatic arthritis	2.4e-05	0.000529	CcSEcCtD
Medroxyprogesterone Acetate—Erythema—Methotrexate—psoriatic arthritis	2.39e-05	0.000525	CcSEcCtD
Medroxyprogesterone Acetate—Malnutrition—Methotrexate—psoriatic arthritis	2.39e-05	0.000525	CcSEcCtD
Medroxyprogesterone Acetate—Hypersensitivity—Prednisolone—psoriatic arthritis	2.36e-05	0.00052	CcSEcCtD
Medroxyprogesterone Acetate—Dyspepsia—Betamethasone—psoriatic arthritis	2.36e-05	0.000519	CcSEcCtD
Medroxyprogesterone Acetate—Dyspepsia—Dexamethasone—psoriatic arthritis	2.36e-05	0.000519	CcSEcCtD
Medroxyprogesterone Acetate—Urticaria—Triamcinolone—psoriatic arthritis	2.34e-05	0.000516	CcSEcCtD
Medroxyprogesterone Acetate—Urticaria—Methylprednisolone—psoriatic arthritis	2.34e-05	0.000515	CcSEcCtD
Medroxyprogesterone Acetate—Dysgeusia—Methotrexate—psoriatic arthritis	2.34e-05	0.000514	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Triamcinolone—psoriatic arthritis	2.33e-05	0.000513	CcSEcCtD
Medroxyprogesterone Acetate—Anaphylactic shock—Prednisone—psoriatic arthritis	2.33e-05	0.000513	CcSEcCtD
Medroxyprogesterone Acetate—Oedema—Prednisone—psoriatic arthritis	2.33e-05	0.000513	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Methylprednisolone—psoriatic arthritis	2.33e-05	0.000512	CcSEcCtD
Medroxyprogesterone Acetate—Decreased appetite—Dexamethasone—psoriatic arthritis	2.33e-05	0.000512	CcSEcCtD
Medroxyprogesterone Acetate—Decreased appetite—Betamethasone—psoriatic arthritis	2.33e-05	0.000512	CcSEcCtD
Medroxyprogesterone Acetate—Infection—Prednisone—psoriatic arthritis	2.32e-05	0.00051	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	2.31e-05	0.000509	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	2.31e-05	0.000509	CcSEcCtD
Medroxyprogesterone Acetate—Back pain—Methotrexate—psoriatic arthritis	2.31e-05	0.000508	CcSEcCtD
Medroxyprogesterone Acetate—Fatigue—Dexamethasone—psoriatic arthritis	2.31e-05	0.000508	CcSEcCtD
Medroxyprogesterone Acetate—Fatigue—Betamethasone—psoriatic arthritis	2.31e-05	0.000508	CcSEcCtD
Medroxyprogesterone Acetate—Shock—Prednisone—psoriatic arthritis	2.29e-05	0.000505	CcSEcCtD
Medroxyprogesterone Acetate—Nervous system disorder—Prednisone—psoriatic arthritis	2.29e-05	0.000503	CcSEcCtD
Medroxyprogesterone Acetate—Tachycardia—Prednisone—psoriatic arthritis	2.27e-05	0.000501	CcSEcCtD
Medroxyprogesterone Acetate—Skin disorder—Prednisone—psoriatic arthritis	2.26e-05	0.000498	CcSEcCtD
Medroxyprogesterone Acetate—Hyperhidrosis—Prednisone—psoriatic arthritis	2.25e-05	0.000496	CcSEcCtD
Medroxyprogesterone Acetate—Anorexia—Prednisone—psoriatic arthritis	2.22e-05	0.000489	CcSEcCtD
Medroxyprogesterone Acetate—Ill-defined disorder—Methotrexate—psoriatic arthritis	2.21e-05	0.000487	CcSEcCtD
Medroxyprogesterone Acetate—Anaemia—Methotrexate—psoriatic arthritis	2.21e-05	0.000486	CcSEcCtD
Medroxyprogesterone Acetate—Feeling abnormal—Betamethasone—psoriatic arthritis	2.21e-05	0.000485	CcSEcCtD
Medroxyprogesterone Acetate—Feeling abnormal—Dexamethasone—psoriatic arthritis	2.21e-05	0.000485	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal pain—Betamethasone—psoriatic arthritis	2.19e-05	0.000482	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	2.19e-05	0.000482	CcSEcCtD
Medroxyprogesterone Acetate—Hypersensitivity—Triamcinolone—psoriatic arthritis	2.17e-05	0.000478	CcSEcCtD
Medroxyprogesterone Acetate—Hypersensitivity—Methylprednisolone—psoriatic arthritis	2.17e-05	0.000477	CcSEcCtD
Medroxyprogesterone Acetate—Malaise—Methotrexate—psoriatic arthritis	2.15e-05	0.000474	CcSEcCtD
Medroxyprogesterone Acetate—Vertigo—Methotrexate—psoriatic arthritis	2.14e-05	0.000472	CcSEcCtD
Medroxyprogesterone Acetate—Urticaria—Betamethasone—psoriatic arthritis	2.13e-05	0.000468	CcSEcCtD
Medroxyprogesterone Acetate—Urticaria—Dexamethasone—psoriatic arthritis	2.13e-05	0.000468	CcSEcCtD
Medroxyprogesterone Acetate—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	2.12e-05	0.000467	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Prednisolone—psoriatic arthritis	2.12e-05	0.000467	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Triamcinolone—psoriatic arthritis	2.12e-05	0.000466	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Betamethasone—psoriatic arthritis	2.12e-05	0.000466	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Betamethasone—psoriatic arthritis	2.12e-05	0.000466	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Dexamethasone—psoriatic arthritis	2.12e-05	0.000466	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Dexamethasone—psoriatic arthritis	2.12e-05	0.000466	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Methylprednisolone—psoriatic arthritis	2.11e-05	0.000465	CcSEcCtD
Medroxyprogesterone Acetate—Insomnia—Prednisone—psoriatic arthritis	2.11e-05	0.000464	CcSEcCtD
Medroxyprogesterone Acetate—Paraesthesia—Prednisone—psoriatic arthritis	2.09e-05	0.000461	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Triamcinolone—psoriatic arthritis	2.09e-05	0.000459	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Methylprednisolone—psoriatic arthritis	2.08e-05	0.000458	CcSEcCtD
Medroxyprogesterone Acetate—Convulsion—Methotrexate—psoriatic arthritis	2.07e-05	0.000455	CcSEcCtD
Medroxyprogesterone Acetate—Dyspepsia—Prednisone—psoriatic arthritis	2.05e-05	0.000452	CcSEcCtD
Medroxyprogesterone Acetate—Chest pain—Methotrexate—psoriatic arthritis	2.03e-05	0.000447	CcSEcCtD
Medroxyprogesterone Acetate—Arthralgia—Methotrexate—psoriatic arthritis	2.03e-05	0.000447	CcSEcCtD
Medroxyprogesterone Acetate—Myalgia—Methotrexate—psoriatic arthritis	2.03e-05	0.000447	CcSEcCtD
Medroxyprogesterone Acetate—Decreased appetite—Prednisone—psoriatic arthritis	2.03e-05	0.000446	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Prednisolone—psoriatic arthritis	2.02e-05	0.000445	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Prednisolone—psoriatic arthritis	2.02e-05	0.000445	CcSEcCtD
Medroxyprogesterone Acetate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	2.02e-05	0.000444	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Methylprednisolone—psoriatic arthritis	2.01e-05	0.000443	CcSEcCtD
Medroxyprogesterone Acetate—Fatigue—Prednisone—psoriatic arthritis	2.01e-05	0.000442	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Prednisolone—psoriatic arthritis	2.01e-05	0.000442	CcSEcCtD
Medroxyprogesterone Acetate—Discomfort—Methotrexate—psoriatic arthritis	2.01e-05	0.000442	CcSEcCtD
Medroxyprogesterone Acetate—Constipation—Prednisone—psoriatic arthritis	1.99e-05	0.000439	CcSEcCtD
Medroxyprogesterone Acetate—Confusional state—Methotrexate—psoriatic arthritis	1.96e-05	0.000432	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Triamcinolone—psoriatic arthritis	1.95e-05	0.000429	CcSEcCtD
Medroxyprogesterone Acetate—Anaphylactic shock—Methotrexate—psoriatic arthritis	1.95e-05	0.000429	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Methylprednisolone—psoriatic arthritis	1.95e-05	0.000428	CcSEcCtD
Medroxyprogesterone Acetate—Infection—Methotrexate—psoriatic arthritis	1.93e-05	0.000426	CcSEcCtD
Medroxyprogesterone Acetate—Feeling abnormal—Prednisone—psoriatic arthritis	1.92e-05	0.000423	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Dexamethasone—psoriatic arthritis	1.92e-05	0.000423	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Betamethasone—psoriatic arthritis	1.92e-05	0.000423	CcSEcCtD
Medroxyprogesterone Acetate—Nervous system disorder—Methotrexate—psoriatic arthritis	1.91e-05	0.00042	CcSEcCtD
Medroxyprogesterone Acetate—Thrombocytopenia—Methotrexate—psoriatic arthritis	1.91e-05	0.00042	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal pain—Prednisone—psoriatic arthritis	1.91e-05	0.00042	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Prednisolone—psoriatic arthritis	1.91e-05	0.000419	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Betamethasone—psoriatic arthritis	1.89e-05	0.000417	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Dexamethasone—psoriatic arthritis	1.89e-05	0.000417	CcSEcCtD
Medroxyprogesterone Acetate—Skin disorder—Methotrexate—psoriatic arthritis	1.89e-05	0.000416	CcSEcCtD
Medroxyprogesterone Acetate—Hyperhidrosis—Methotrexate—psoriatic arthritis	1.88e-05	0.000414	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Triamcinolone—psoriatic arthritis	1.88e-05	0.000413	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Methylprednisolone—psoriatic arthritis	1.87e-05	0.000412	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Triamcinolone—psoriatic arthritis	1.86e-05	0.000409	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Triamcinolone—psoriatic arthritis	1.86e-05	0.000409	CcSEcCtD
Medroxyprogesterone Acetate—Anorexia—Methotrexate—psoriatic arthritis	1.86e-05	0.000409	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Methylprednisolone—psoriatic arthritis	1.86e-05	0.000408	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Methylprednisolone—psoriatic arthritis	1.85e-05	0.000408	CcSEcCtD
Medroxyprogesterone Acetate—Urticaria—Prednisone—psoriatic arthritis	1.85e-05	0.000408	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Triamcinolone—psoriatic arthritis	1.85e-05	0.000407	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Methylprednisolone—psoriatic arthritis	1.84e-05	0.000406	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Prednisone—psoriatic arthritis	1.84e-05	0.000406	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Prednisone—psoriatic arthritis	1.84e-05	0.000406	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Dexamethasone—psoriatic arthritis	1.83e-05	0.000403	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Betamethasone—psoriatic arthritis	1.83e-05	0.000403	CcSEcCtD
Medroxyprogesterone Acetate—Hypotension—Methotrexate—psoriatic arthritis	1.82e-05	0.000401	CcSEcCtD
Medroxyprogesterone Acetate—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	1.77e-05	0.000391	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Betamethasone—psoriatic arthritis	1.77e-05	0.00039	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Dexamethasone—psoriatic arthritis	1.77e-05	0.00039	CcSEcCtD
Medroxyprogesterone Acetate—Insomnia—Methotrexate—psoriatic arthritis	1.76e-05	0.000388	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Triamcinolone—psoriatic arthritis	1.75e-05	0.000386	CcSEcCtD
Medroxyprogesterone Acetate—Paraesthesia—Methotrexate—psoriatic arthritis	1.75e-05	0.000385	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Methylprednisolone—psoriatic arthritis	1.75e-05	0.000385	CcSEcCtD
Medroxyprogesterone Acetate—Dyspnoea—Methotrexate—psoriatic arthritis	1.74e-05	0.000382	CcSEcCtD
Medroxyprogesterone Acetate—Somnolence—Methotrexate—psoriatic arthritis	1.73e-05	0.000381	CcSEcCtD
Medroxyprogesterone Acetate—Hypersensitivity—Prednisone—psoriatic arthritis	1.72e-05	0.000378	CcSEcCtD
Medroxyprogesterone Acetate—Dyspepsia—Methotrexate—psoriatic arthritis	1.71e-05	0.000377	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Betamethasone—psoriatic arthritis	1.7e-05	0.000375	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Dexamethasone—psoriatic arthritis	1.7e-05	0.000375	CcSEcCtD
Medroxyprogesterone Acetate—Decreased appetite—Methotrexate—psoriatic arthritis	1.69e-05	0.000373	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Dexamethasone—psoriatic arthritis	1.69e-05	0.000371	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Betamethasone—psoriatic arthritis	1.69e-05	0.000371	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Betamethasone—psoriatic arthritis	1.69e-05	0.000371	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Dexamethasone—psoriatic arthritis	1.69e-05	0.000371	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	1.68e-05	0.00037	CcSEcCtD
Medroxyprogesterone Acetate—Fatigue—Methotrexate—psoriatic arthritis	1.68e-05	0.00037	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Dexamethasone—psoriatic arthritis	1.68e-05	0.000369	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Betamethasone—psoriatic arthritis	1.68e-05	0.000369	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Prednisone—psoriatic arthritis	1.67e-05	0.000368	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Prednisone—psoriatic arthritis	1.65e-05	0.000363	CcSEcCtD
Medroxyprogesterone Acetate—Feeling abnormal—Methotrexate—psoriatic arthritis	1.61e-05	0.000353	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Prednisone—psoriatic arthritis	1.59e-05	0.000351	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal pain—Methotrexate—psoriatic arthritis	1.59e-05	0.000351	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Betamethasone—psoriatic arthritis	1.59e-05	0.00035	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Dexamethasone—psoriatic arthritis	1.59e-05	0.00035	CcSEcCtD
Medroxyprogesterone Acetate—Urticaria—Methotrexate—psoriatic arthritis	1.55e-05	0.000341	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Prednisone—psoriatic arthritis	1.54e-05	0.000339	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Methotrexate—psoriatic arthritis	1.54e-05	0.000339	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Methotrexate—psoriatic arthritis	1.54e-05	0.000339	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Prednisone—psoriatic arthritis	1.48e-05	0.000326	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Prednisone—psoriatic arthritis	1.47e-05	0.000323	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Prednisone—psoriatic arthritis	1.47e-05	0.000323	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Prednisone—psoriatic arthritis	1.46e-05	0.000321	CcSEcCtD
Medroxyprogesterone Acetate—Hypersensitivity—Methotrexate—psoriatic arthritis	1.44e-05	0.000316	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Methotrexate—psoriatic arthritis	1.4e-05	0.000308	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Prednisone—psoriatic arthritis	1.38e-05	0.000305	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Methotrexate—psoriatic arthritis	1.38e-05	0.000303	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Methotrexate—psoriatic arthritis	1.33e-05	0.000293	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Methotrexate—psoriatic arthritis	1.29e-05	0.000284	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Methotrexate—psoriatic arthritis	1.24e-05	0.000273	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Methotrexate—psoriatic arthritis	1.23e-05	0.00027	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Methotrexate—psoriatic arthritis	1.23e-05	0.00027	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Methotrexate—psoriatic arthritis	1.22e-05	0.000269	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Methotrexate—psoriatic arthritis	1.16e-05	0.000255	CcSEcCtD
